Specific immuno capturing of the staphylococcal superantigen toxic-shock syndrome toxin-1 in plasma

Biotechnology and Bioengineering

Volumn 104, Issue 1, 2009, Pages 143-151

  Adams, Hendrik ^a,b   Brummelhuis, Walter ^c   Maassen, Bram ^a   Van Egmond, Nathalie ^b   El Khattabi, Mohamed ^a   Detmers, Frank ^b   Hermans, Pim ^b   Braam, Branko ^c,d   Stam, Jord ^a   Verrips, Theo ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b BAC BV   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

Plasmafiltration; Scavenging chromatography; Single chain antibodies; Superantigen; Toxic shock syndrome; VHH

Indexed keywords

PLASMAFILTRATION; SINGLE-CHAIN ANTIBODIES; SUPERANTIGEN; TOXIC-SHOCK SYNDROME; VHH;

AFFINITY CHROMATOGRAPHY; ANTIBODIES; CELL MEMBRANES; CELL PROLIFERATION; CHROMATOGRAPHIC ANALYSIS; PLASMAS;

TOXIC MATERIALS;

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY VHH; TOXIC SHOCK SYNDROME TOXIN 1; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BINDING AFFINITY; BLOOD LEVEL; CONTROLLED STUDY; FAST PROTEIN LIQUID CHROMATOGRAPHY; NONHUMAN; PHAGE DISPLAY; PLASMA; YEAST;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; CAMELIDS, NEW WORLD; CHROMATOGRAPHY, AFFINITY; ENTEROTOXINS; HUMANS; PLASMA; PROTEIN BINDING; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS;

LAMA (MAMMAL); POSIBACTERIA; STAPHYLOCOCCUS AUREUS; SUIDAE;

EID: 69249133338     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.22365     Document Type: Article

References (25)

1. Drenger B, Israeli A, Or R, Leitersdorf E. 1985. Plasmapheresis for streptococcal sepsis? Lancet 2:943.
2. Dumoulin M, Conrath K, Van Meirhaeghe A, Meersman F, Heremans K, Frenken LG, Muyldermans S, Wyns L, Matagne A. 2002. Single-domain antibody fragments with high conformational stability. Protein Sci 11:500-515. (Pubitemid 34171255)
3. El Khattabi M, Adams H, Heezius E, Hermans P, Detmers F, Maassen B, van der Ley P, Tommassen J, Verrips T, Stam J. 2006. Llama single-chain antibody that blocks lipopolysaccharide binding and signaling: Prospects for therapeutic applications. Clin Vaccine Immunol 13:1079-1086. (Pubitemid 44622533)
4. Ewert S, Cambillau C, Conrath K, Plückthun A. 2002. Biophysical properties of camelid V(HH) domains compared to those of human V(H)3 domains. Biochemistry 41:3628-3636.
5. Fenwick P, Ryan C, Sriskandan S, Cohen J. 2003. Application of a rat model of streptococcal shock to evaluate on-line hemoperfusion and removal of circulating superantigens. Crit Care Med 31:171-178. (Pubitemid 36151168)
6. Frenken LG, van der Linden RH, Hermans PW, Bos JW, Ruuls RC, de Geus B, Verrips CT. 2000. Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae. J Biotechnol 78:11-21.
7. Hamers-Casterman C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, Songa EB, Bendahman N, Hamers R. 1993. Naturally occurring antibodies devoid of light chains. Nature 363:446-448. (Pubitemid 23179389)
8. Harmsen MM, De Haard HJ. 2007. Properties, production, and applications of camelid single-domain antibody fragments. Appl Microbiol Biotechnol 77:13-22.
9. Harmsen MM, Van Solt CB, Fijten HP, Van Setten MC. 2005. Prolonged in vivo residence times of llama single-domain antibody fragments in pigs by binding to porcine immunoglobulins. Vaccine 23:4926-4934.
10. HoogenboomHR, de Bruine AP, Hufton SE, Hoet RM, Arends JW, Roovers RC. 1998. Antibody phage display technology and its applications. Immunotechnology 4:1-20. (Pubitemid 28302180)
11. Joosten V, Lokman C, Van Den Hondel CA, Punt PJ. 2003. The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi. Microb Cell Fact 2:1
12. Klooster R, Maassen BT, Stam JC, Hermans PW, Ten Haaft MR, Detmers FJ, de Haard HJ, Post JA, Theo Verrips C. 2007. Improved anti-IgG and HSA affinity ligands: Clinical application of VHH antibody technology. J Immunol Methods 324:1-12. (Pubitemid 47001423)
13. Lopes TS, Hakkaart GJ, Koerts BL, Raue HA, Planta RJ. 1991. Mechanism of high-copy-number integration of pMIRY-type vectors into the ribosomal DNA of Saccharomyces cerevisiae. Gene 105:83-90.
14. Lopes TS, de Wijs IJ, Steenhauer SI, Verbakel J, Planta RJ. 1996. Factors affecting the mitotic stability of high-copy-number integration into the ribosomal DNA of Saccharomyces cerevisiae. Yeast 12:467-477. (Pubitemid 26157852)
15. Miwa K, Fukuyama M, Ida N, Igarashi H, Uchiyama T. 2003. Preparation of a superantigen-adsorbing device and its superantigen removal efficacies in vitro and in vivo. Int J Infect Dis 7:21-26. (Pubitemid 36358872)
16. Miwa K, Fukuyama M, Matsuno N, Masuda S, Oyama Y, Ikeda K, Ikeda T. 2006a. Superantigen-induced multiple organ dysfunction in a toxinconcentration- controlled and sequential parameter-monitored swine sepsis model. Int J Infect Dis 10:14-24. (Pubitemid 43003587)
17. Miwa K, Fukuyama M, Matsuno N, Shimada K, Ikeda K, Ikeda T. 2006b. Physiological response to superantigen-adsorbing hemoperfusion in toxin-concentration-controlled septic swine. Blood Purif 24:319-326. (Pubitemid 43800673)
18. Muyldermans S. 2001. Single domain camel antibodies: Current status. J Biotechnol 74:277-302.
19. Muyldermans S, Atarhouch T, Saldanha J, Barbosa JA, Hamers R. 1994. Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains. Protein Eng 7:1129-1135. (Pubitemid 24282500)
20. Scharfman WB, Tillotson JR, Taft EG, Wright E. 1979. Plasmapheresis for meningococcemia with disseminated intravascular coagulation. N Engl J Med 300:1277-1278.
21. Taniguchi T, Hirai F, Takemoto Y, Tsuda K, Yamamoto K, Inaba H, Sakurai H, Furuyoshi S, Tani N. 2006. A novel adsorbent of circulating bacterial toxins and cytokines: The effect of direct hemoperfusion with CTR column for the treatment of experimental endotoxemia. Crit Care Med 34:800-806. (Pubitemid 43308273)
22. van der Linden RH, Frenken LG, de Geus B, Harmsen MM, Ruuls RC, Stok W, de Ron L, Wilson S, Davis P, Verrips CT. 1999. Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies. Biochim Biophys Acta 1431: 37-46. (Pubitemid 29182720)
23. Venkataraman R, Subramanian S, Kellum JA. 2003. Clinical review: Extracorporeal blood purification in severe sepsis. Crit Care 7:139-145. (Pubitemid 36432672)
24. Verheesen P, Roussis A, de Haard HJ, Groot AJ, Stam JC, den Dunnen JT, Frants RR, Verkleij AJ, Theo Verrips C, van der Maarel SM. 2006. Reliable and controllable antibody fragment selections from Camelid non-immune libraries for target validation. Biochim Biophys Acta 1764:1307-1319. (Pubitemid 44403970)
25. Witholt B, Boekhout M, Brock M, Kingma J, Heerikhuizen HV, Leij LD. 1976. An efficient and reproducible procedure for the formation of spheroplasts from variously grown Escherichia coli. Anal Biochem 74:160-170.